Interferon beta-1a clinical trials
4 indexed studies · 1 currently recruiting
- Active not recruitingPHASE3
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
This study looks at how safe and effective two medicines, fingolimod and interferon beta-1a, are for young people aged 10-17 with multiple sclerosis (MS). It compares them to see which works best and is safest.
For: Multiple SclerosisUnited States · Australia · Austria - Ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-Label, Rater-Blind, Randomized, Multi-Center, Parallel-Arm, Active-Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC monthly vs. First Line DMT - physician’s choice in the treatment of newly diagnosed RMS (STHENOS)
This study is testing a new way to treat multiple sclerosis (MS) called ofatumumab. It compares this new treatment to standard MS medications in people recently diagnosed with a specific type of MS called relapsing multiple sclerosis (RMS). The aim is to see which treatment works best to prevent MS attacks and stop the disease from getting worse.
For: relapsing multiple sclerosis (RMS)France · Germany · Italy - RecruitingPHASE3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
This study, called REMAP-CAP, looks at different treatments for serious lung infections like pneumonia, flu, and COVID-19 in adults needing intensive care. It aims to find out which treatments work best to help patients recover.
For: Community-acquired Pneumonia, Influenza, COVID-19United States · Australia · Belgium - AuthorisedTherapeutic confirmatory (Phase III)
DESIRE MS: A prospective randomized non-inferiority trial comparing anti-CD20 maintenance versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
This study compares different treatments for multiple sclerosis (MS) to see if a less intense approach is just as good as current treatments. It looks at how well people's MS is controlled over three years and checks for new symptoms or changes in brain scans.
For: Multiple sclerosisFrance